drugset
drugset / Trial / NCT03936166

A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers

NCT03936166 ↗

Phase 1 Completed 57 enrolled Crinetics Pharmaceuticals Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Phase 1, double-blind, randomized, placebo-controlled, single-dose and multiple-dose study of CRN01941 in up to 119 healthy male and female subjects. This single-center study will be conducted in 3 parts: a single-ascending dose phase (up to 8 cohorts, 8 subjects/cohort), a multiple-ascending dose phase (up to 5 cohorts, 9 subjects/cohort), and single dose phase in elderly subjects (1 cohort, 10 subjects).

Timeline

Start
2019-04-29
Primary completion
2019-12-16
Completion
2019-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject CRN01941 Unknown — Oral

Indications

No indication recorded.